| Trial ID: | L4300 |
| Source ID: | NCT01541735
|
| Associated Drug: |
Pantoprazole
|
| Title: |
Pantoprazole on Insulin Secretion in Diabetes
|
| Acronym: |
IBP
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01541735/results
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Pantoprazole|DRUG: placebo
|
| Outcome Measures: |
Primary: First Phase of Insulin Secretion, The hyperglycemic-hyperinsulinemic clamp technique is perform to assess the phases of insulin secretion: first, late and total insulin secretion., Change from Baseline at 45 days. (plus or minus 3 days)|Second Phase of Insulin Secretion, Change from baseline in first phase insulin secretion at 45 day. (plus or minus 3 days), Baseline and 45 day|Total Insulin Secretion, The hyperglycemic-hyperinsulinemic clamp technique is performed to assess the total insulin secretion, Change from baseline of total insulin secretion at 45 day (plus or minus 3 days) | Secondary: Glycated Hemoglobin A1C, Change from Baseline in glycated hemoglobin A1C at 45 day.
|
| Sponsor/Collaborators: |
Sponsor: Coordinación de Investigación en Salud, Mexico
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
14
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2012-01
|
| Completion Date: |
2013-05
|
| Results First Posted: |
2014-02-21
|
| Last Update Posted: |
2014-02-21
|
| Locations: |
Instituto Mexicano del Seguro Social. Hospital de Especialidades., Guadalajara, Jalisco, 44380, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT01541735
|
